MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Treatment"

  • MDS Virtual Congress 2020

    Examining the Effects of a Dental Mouthpiece on Motor Signs in Parkinson’s Disease

    D. May, K. Rawson, D. Moeller, L. Tueth, R. Duncan, E. Harrison, A. Horin, P. Myers, G. Earhart (St. Louis, MO, USA)

    Objective: To determine if the use of a dental mouthpiece affects motor functioning for people with Parkinson’s disease (PD). Background: Several case studies have shown…
  • MDS Virtual Congress 2020

    Transcutaneous magnetic spinal cord stimulation for freezing of gait in Parkinson’s disease (PD)

    J.R Menezes, R.B Carra, G.A Nunes, J.S Simões, M.J Teixeira, K.P Duarte, D.C Andrade, E.R Barbosa, M.A Marcolin, R.G Cury (São Paulo, Brazil)

    Objective: To study the safety and efficacy of transcutaneous magnetic spinal cord stimulation (SCS) on freezing of gait (FoG) and other motor symptoms in a…
  • MDS Virtual Congress 2020

    Music-based interventions for the management of movement disorders: a systematic literature review

    S. Saade-Lemus, J. Martin-Saavedra, A. Deik (Philadelphia, PA, USA)

    Objective: To conduct a systematic review of the current evidence regarding the use of music-based interventions for the management of patients with movement disorders. Background:…
  • MDS Virtual Congress 2020

    CHIEF-PD: Cholinesterase Inhibitor to prEvent Falls in Parkinson’s Disease

    S. Neumann, J. Taylor, A. Bamford, C. Metcalfe, D.M Gaunt, A. Whone, D. Steeds, S.R Emmett, W. Hollingworth, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: Preventing falls in people with Parkinson’s disease has the potential to reduce hospital admissions and improve quality of life by diminishing the significant morbidity…
  • MDS Virtual Congress 2020

    Brain activity underpinning visual cues for gait impairment in Parkinson’s disease

    S. Stuart, J. Wagner, S. Makeig, M. Mancini (Portland, OR, USA)

    Objective: To examine brain activity when walking with and without visual cues in Parkinson’s disease (PD). Background: Gait impairments and Freezing of Gait (FOG) in…
  • MDS Virtual Congress 2020

    Serious games home rehabilitation program to treat gait and balance disorders in patients with Parkinson’s disease: A randomised controlled trial

    D. Nuic, S. de Weijer, E. Zeeboer, C. Olivier, S. Cherif, P. Foulon, B.R Bloem, N. De Vries, M.L Welter (Paris, France)

    Objective: To test the efficacy of an exergame rehabilitation programme at home to treat dopa-resistant gait and balance disorders in Parkinson’s disease (PD) patients. Background:…
  • MDS Virtual Congress 2020

    Precise evaluation and exercise prescription for Parkinson’s disease

    H. Ziyi (Dalian, China)

    Objective: To study the intervention effect of the exercise prescription centered on Baduanjin for patients with early Parkinson's disease, and to explore the possibility of…
  • MDS Virtual Congress 2020

    A Patient with Gait Disturbance Caused by Parkinson’s Disease: A Case Report

    M. Park, SS. Park, S.H Lee, C.Y Kim, I.W Choi, I.C Chae, H.R Yoo (Daejeon, Republic of Korea)

    Objective: It is well known that mental simulation of movement in the brain can facilitate motor rehabilitation. Our hypothesis is: can a direct, sequential stimulation…
  • MDS Virtual Congress 2020

    Adrenoleukodystrophy Spastic Gait: Treatment with Fampridine

    E. Gisbert Tijeras, N. López Aríztegui, M.I Morales Casado, F. Muñoz Escudero, A. Fernández, N. García Alvarado, Á. Jamilena López, A. Fernández-Corada (Toledo, Spain)

    Objective: Report a possible alternative treatment for spastic gait in 2 adult patients with adrenoleukodystrophy. Background: X-linked adrenoleukodystrophy is a peroxisomal hereditary disease with tissue…
  • MDS Virtual Congress 2020

    Improving automaticity of walking in Parkinson’s disease: Levodopa or Donepezil?

    S. Stuart, R. Morris, A. Giritharan, J. Quinn, J. Nutt, M. Mancini (Newcastle upon Tyne, United Kingdom)

    Objective: Determine whether levodopa replacement or cholinergic augmentation improve automaticity of walking in people with Parkinson’s disease (PD). Background: Degradation of dopaminergic striatal mechanisms of…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 36
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley